Septo-optic dysplasia.
Fard
M A
MA
The Neuro-Ophthalmology Division, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA.
Wu-Chen
W Y
WY
Man
B L
BL
Miller
N R
NR
D000324:Adrenocorticotropic Hormone / Q000172:deficiency; D002675:Child, Preschool; D005260:Female; D013006:Growth Hormone / Q000172:deficiency; D018398:Homeodomain Proteins / Q000235:genetics; D006801:Humans; D007018:Hypopituitarism / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D007223:Infant; D008297:Male; D009900:Optic Nerve / Q000002:abnormalities* / Q000503:physiopathology; D025962:Septo-Optic Dysplasia / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy*; D012688:Septum Pellucidum / Q000002:abnormalities* / Q000503:physiopathology; D013972:Thyrotropin / Q000172:deficiency; D014792:Visual Acuity / Q000502:physiology
C489736:HESX1 protein, human; D018398:Homeodomain Proteins; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone